Insider buying last 90 days
No open-market insider purchases were filed for MS in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 4 close
Morgan Stanley's own research desk generated most of this week's headlines rather than company-specific news about the firm itself. Analysts including Stephen Byrd discussed a path forward for data center development, while the firm flagged Texas risk for Cipher, Galaxy and MARA following a gubernatorial election result, and issued a string of price target changes on names including Fiserv, Block, Marathon Petroleum, Skyworks Solutions and Flywire. Separately, Morgan Stanley built out its wealth business, recruiting advisor teams from Merrill Lynch and RBC Wealth Management to form a new San Francisco practice managing over $3 billion in assets.
Shares closed at $193.99, up 4.2%, sitting between the 50-day average of $196.50 and the 200-day average of $194.35, a mixed trend signal. The GekkoIndex reads 57.1, placing MS in the Neutral zone, down 2.3 over five days. Price sits 4.3% below Gekko Fair Value of $202.77.
The next earnings date falls on 14 January 2027, 70 days out and beyond a typical 20-trading-day hold; the prior report on 14 October 2026 beat estimates with EPS of $3.03 versus $2.93 expected, though shares reacted -2.4%. No insider, Congress or unusual options activity appears in the respective windows. Seasonally, the next 20 trading days have averaged +5.8% over 5 years, rising in 4 of them. Consensus among 18 firms includes 8 buy, 9 hold and 1 sell ratings, with a target of $211.50.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Morgan Stanley scores 2 supportive, 3 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive3 mixed0 headwinds
Averages disagree
Close $193.99 sits between the 50-day ($196.50) and 200-day ($194.35) averages, or the averages disagree.
See the chart57.1, Neutral
Reading 57.1 is in the Neutral zone.
See the GekkoIndex4.3% below
Price is within 5% of Gekko Fair Value (4.3% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 70 days
Next report Jan 14, 2027, 70 days away — outside a typical 20-trading-day hold.
See earnings+5.8% on average
From this point in the calendar, the next 20 trading days averaged +5.8% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Morgan Stanley closed at $193.99 on Nov 4, 2026, +18.5% over the past year, inside a 52-week range of $152.80 to $232.25.
Use the left and right arrow keys to read daily values.
Put MS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Morgan Stanley is a financial holding company that provides a wide range of financial services to corporations, governments, financial institutions, and individual clients around the world, including the Americas, Europe, the Middle East, Africa, and Asia. It is known for its work in capital raising, financial advisory, and wealth management, serving as a link between large institutional needs and individual investor services.
The firm runs its business through three divisions. Institutional Securities handles underwriting, mergers and acquisitions advice, corporate restructuring, real estate and project financing, and sales and trading across equity, fixed income, currency, and commodity markets, along with lending and research services. Wealth Management serves individual investors and smaller businesses and institutions, offering brokerage, financial planning, workplace stock plans, insurance and annuity products, and various lending and banking services. Investment Management develops equity, fixed income, liquidity, and alternative investment products for institutional and intermediary clients such as pension plans, foundations, endowments, governments, sovereign wealth funds, insurers, and fund sponsors.
Morgan Stanley's shares are listed on the NYSE under the ticker MS.
Morgan Stanley’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 57.1, in the Neutral zone, down 2.3 points over five sessions.
Down 2.3 points over five sessions.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 26 | +2.9% | +0.8% | ||
| Accumulation | 131 | +0.1% | +3.3% | ||
| Neutral (current zone) | 462 | +0.8% | +2.6% | ||
| Distribution | 74 | +0.1% | +1.3% | ||
| Selling | 4 | Too few readings yet | |||
Average MS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Morgan Stanley trades 4.3% below Gekko Fair Value of $202.77, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Morgan Stanley shares are worth, recalculated every trading day.
$202.77
Gekko Fair Value, Nov 4, 2026
4.3% below fair value · About fair value
At the end of Aug 2026 the price was 7.0% below the estimate.
No open-market insider purchases were filed for Morgan Stanley, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for MS in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in MS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Morgan Stanley has been buying back its own shares.
From company filings.
2of the funds Gekko tracks hold MS.
Morgan Stanley reports on Jan 14, 2027, before the open (70 days away), and beat the EPS estimate in 8 of its last 8 reports.
Jan 14, 2027
Expected before the open, 70 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 14, 2026 | $3.03 est $2.93 | $20.34B est $19.93B | −2.4% |
| Jul 15, 2026 | $3.46 est $2.89 | $21.35B est $19.67B | −4.1% |
| Apr 15, 2026 | $3.43 est $3.02 | $20.58B est $19.74B | +2.2% |
| Jan 15, 2026 | $2.68 est $2.40 | $17.89B est $17.74B | +4.6% |
| Oct 15, 2025 | $2.80 est $2.10 | $17.08B est $16.69B | +3.0% |
| Jul 16, 2025 | $2.13 est $1.98 | $15.60B est $16.07B | −0.5% |
| Apr 11, 2025 | $2.60 est $2.21 | $16.52B est $16.54B | +2.4% |
| Jan 16, 2025 | $2.22 est $1.69 | $15.04B est $15.03B | +5.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Morgan Stanley is $211.50, +9.0% from the last close, from 18 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 18 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 2 | UBS | $240 | +23.7% |
| Oct 23 | Freedom Capital Markets | $210 | +8.3% |
| Oct 19 | BMO Capital | $210 | +8.3% |
| Oct 18 | JLPascual | $129 | −33.5% |
| Oct 16 | J.P. Morgan | $198 | +2.1% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, Morgan Stanley averaged +5.8% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +4.3% | 3 of 5 |
| Next 10 trading days | +4.2% | 3 of 5 |
| Next 15 trading days | +4.5% | 4 of 5 |
| Next 20 trading days | +5.8% | 4 of 5 |
| Next 30 trading days | +6.8% | 4 of 5 |
For scale, MS’s typical 20-trading-day move in either direction is about 5.6%.
Morgan Stanley’s market cap is $306.0B, with a P/E ratio of 14.7 and revenue of $79.79B over the last twelve months.
Coverage of Morgan Stanley this week reads positive: 9 positive, 3 neutral and 0 negative headlines.
Morgan Stanley’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| BLKBlackRock | Neutral | 1.5% above |
| UBSUBS | Neutral | 2.7% below |
| BXBlackstone | Neutral | 2.3% below |
| BNBrookfield | Distribution | 3.0% below |
| KKRKKR | Neutral | 4.6% below |
| BAMBrookfield Asset Management | Distribution | 6.9% above |
A peer links to its own page where one exists.
Morgan Stanley’s market cap is $306.0B at the Nov 4, 2026 close of $193.99, with 1.57B shares outstanding. The shares trade on a P/E ratio of 14.7.
The consensus analyst 12-month price target for Morgan Stanley is $211.50, +9.0% from the last close. Of the 18 firms that rated the stock in the last 90 days, 8 rate it a buy, 9 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Morgan Stanley is about fair value: the Nov 4, 2026 close of $193.99 is 4.3% below Gekko Fair Value of $202.77. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Morgan Stanley is expected to report on Jan 14, 2027, before the market opens (70 days away). Analysts expect earnings of $2.93 per share on revenue of $20.26B. Morgan Stanley beat the earnings estimate in 8 of its last 8 reports, moving 3.1% on average across the report.
Morgan Stanley’s 52-week high is $232.25 and its 52-week low is $152.80; it closed at $193.99 on Nov 4, 2026, +18.5% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (earnings risk and seasonality), 3 as mixed (trend, gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.